Search Orphan Drug Designations and Approvals
-
Generic Name: | Allogeneic multi-tumor-associated antigen-specific T cell product |
---|---|
Date Designated: | 04/28/2020 |
Orphan Designation: | Treatment of acute myeloid leukemia |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Marker Therapeutics, Inc. 3200 Southwest Freeway Suite 2240 Houston, Texas 77027 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-